share_log

Arrowhead Pharmaceuticals | 8-K: Arrowhead Pharmaceuticals Reports Fiscal 2024 Second Quarter Results

SEC ·  May 9 17:10
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more